Trial Profile
Translational Research of Phase II study of FOLFIRI+Ramucirumab with early recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin / fluoropyrimidine (RAINCLOUD)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2023
Price :
$35
*
At a glance
- Drugs Ramucirumab (Primary) ; Fluoropyrimidine derivatives; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Biomarker; Pharmacodynamics
- Acronyms RAINCLOUD-TR
- 21 Jan 2023 Results (n=81) assessing clinical development and evaluation of plasma angiogenesis factors, presented at the 2023 Gastrointestinal Cancers Symposium
- 17 Aug 2017 New trial record